ArticleInternational journal of molecular sciences2025

Synergistic HDAC4/8 Inhibition Sensitizes Osteosarcoma to Doxorubicin via pAKT/RUNX2 Pathway Modulation.

Anuja Gajanan Magar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.